查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526281

全球診斷影像市場

Diagnostic Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 537 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年全球診斷影像市場將達到410億美元

全球診斷影像市場預計 2023 年為 290 億美元，預計到 2030 年將達到 410 億美元，2023 年至 2030 年複合年成長率為 5.0%。 X 光成像是本報告分析的細分市場之一，預計複合年成長率為 4.5%，到分析期結束時將達到 94 億美元。在分析期間，MRI 領域的複合年成長率估計為 5.4%。

美國市場預估成長88億美元，中國複合年增率為7.2%

預計 2023 年美國診斷影像市場規模將達 88 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達52億美元，2023-2030年分析期間複合年成長率為7.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.2% 和 4.4%。在歐洲，德國的複合年成長率預計為 4.2%。

全球診斷影像市場 - 主要趨勢和促進因素總結

診斷影像是現代醫學的重要工具，可實現內部結構的非侵入性視覺化，從而有效診斷、監測和治療醫療狀況。該領域包括放射線照相、電腦斷層掃描 (CT)、磁振造影(MRI)、超音波和核子醫學，包括正子斷層掃描 (PET) 和單光子發射斷層掃描 (SPECT) 等多種技術。這些模式中的每一種都有不同的目的，並根據所檢查的特定疾病狀態或區域進行選擇。例如，X光通常用於觀察骨骼和檢測骨折，但透過 MRI 可以更好地觀察軟組織。超音波經常用於產科和心臟病學，以檢查懷孕期間的胎兒並評估心臟功能。核醫學提供有關人體的功能資訊，檢測分子活性，並可以在其他影像檢查發現疾病之前早期識別疾病。

技術進步大大提高了診斷成像能力。數位成像和 3D 重建等技術創新提高了影像品質並減少了輻射暴露。人工智慧 (AI) 和影像處理技術的融合正在徹底改變這一領域，實現更快、更準確的影像分析。人工智慧演算法可以幫助檢測人眼可能錯過的模式，幫助放射科醫師更有效地診斷癌症等疾病。此外，可攜式診斷影像設備的發展擴大了診斷服務的範圍，並實現了照護現場服務，這在緊急情況、農村地區和資源貧乏地區尤其有價值。這種增加的可近性對於及時診斷和治療至關重要，並對患者的治療結果產生重大影響。此外，PET/CT和PET/MRI等混合成像技術的進步使得同時對解剖和生化特徵進行成像成為可能，從而可以對疾病進行更全面的評估和準確的診斷，這對於識別和管理非常有用。

診斷影像市場的成長受到多種因素的推動，例如全球人口老化、慢性病盛行率上升、診斷影像方式的技術進步以及醫療保健支出的增加。隨著人口老化，心血管疾病、癌症和神經病變等疾病的發生率不斷增加，需要診斷影像來有效管理所有這些疾病。慢性病在所有年齡層也變得越來越常見，需要頻繁的監測和評估，從而支持了對診斷影像服務的需求。技術進步不僅提高了診斷影像的品質和效率，而且擴大了其應用範圍並導致更廣泛的臨床實施。此外，全球醫療保健系統越來越注重預防保健和早期診斷，這進一步推動了對先進影像解決方案的需求。對醫療保健基礎設施的投資增加，特別是在新興國家，以及對混合和先進診斷成像模式的接受程度不斷提高，也促進了市場的穩定成長。因此，診斷影像仍然是現代醫學的重要組成部分，不斷的創新確保了其在醫療保健服務中不斷擴大的作用。

受訪企業範例（共66家）

  • Barco NV
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Brainlab AG
  • Adelaide Health Care
  • Bracco Diagnostics, Inc.
  • Accuray, Inc.
  • Bracco SpA
  • Biodex Medical Systems, Inc.
  • Brain Scientific Inc.
  • Alliance Medical Limited
  • Asahi Roentgen Ind. Co., Ltd.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Beijing Wandong Medical Technology Co., Ltd.
  • Bonraybio Company Limited

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 寵物
  • 主要企業
  • 市場趨勢和促進因素
  • SPECT-CT
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP11515

Global Diagnostic Imaging Market to Reach US$41.0 Billion by 2030

The global market for Diagnostic Imaging estimated at US$29.0 Billion in the year 2023, is expected to reach US$41.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.8 Billion While China is Forecast to Grow at 7.2% CAGR

The Diagnostic Imaging market in the U.S. is estimated at US$8.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diagnostic Imaging Market - Key Trends & Drivers Summarized

Diagnostic imaging is a critical tool in modern medicine, enabling the visualization of the internal structures of the body non-invasively to diagnose, monitor, and treat medical conditions effectively. This field includes a variety of techniques such as X-ray radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine including positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Each of these modalities serves distinct purposes and is chosen based on the specific medical conditions and the part of the body being examined. For instance, X-rays are often used for viewing bones and detecting fractures, while soft tissues are better visualized by MRI. Ultrasound is frequently used in obstetrics and cardiology to examine the fetus during pregnancy and assess cardiac functions. Nuclear medicine provides functional information about a person’s body, detecting molecular activity and can pinpoint disease in its earliest stages before they are apparent with other imaging tests.

Technological advancements have vastly improved the capabilities of diagnostic imaging. Innovations such as digital imaging and 3D reconstruction have enhanced image quality and reduced exposure to radiation. The integration of artificial intelligence (AI) with imaging technologies is transforming the field, enabling faster and more accurate analyses of images. AI algorithms help in detecting patterns that may be missed by the human eye, assisting radiologists in diagnosing diseases such as cancer more effectively. Furthermore, the development of portable imaging devices has expanded the reach of diagnostic services, allowing for point-of-care services that are particularly valuable in emergency settings and in rural or under-resourced areas. This accessibility improvement is vital for timely diagnosis and treatment, significantly impacting patient outcomes. Additionally, advances in hybrid imaging techniques, such as PET/CT and PET/MRI, allow for simultaneous imaging of anatomical and biochemical functions, providing a more comprehensive assessment and aiding in precise disease localization and management.

The growth in the diagnostic imaging market is driven by several factors, including the aging global population, the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing healthcare expenditure. As the population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancers, and neurological disorders, all of which require diagnostic imaging for effective management. Chronic diseases are also becoming more common across all age groups, necessitating frequent monitoring and evaluation, which supports the demand for imaging services. Technological advancements not only enhance the quality and efficiency of diagnostic imaging but also expand its applications, leading to broader clinical adoption. Additionally, healthcare systems worldwide are focusing more on preventive care and early diagnosis, which further drives the demand for advanced imaging solutions. The increasing investment in healthcare infrastructure, especially in emerging economies, and the growing acceptance of hybrid and advanced imaging modalities contribute to the robust growth of this market. Thus, diagnostic imaging continues to be an indispensable part of modern medical practice, with ongoing innovations ensuring its expanding role in healthcare delivery.

Select Competitors (Total 66 Featured) -

  • Barco NV
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Brainlab AG
  • Adelaide Health Care
  • Bracco Diagnostics, Inc.
  • Accuray, Inc.
  • Bracco SpA
  • Biodex Medical Systems, Inc.
  • Brain Scientific Inc.
  • Alliance Medical Limited
  • Asahi Roentgen Ind. Co., Ltd.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Beijing Wandong Medical Technology Co., Ltd.
  • Bonraybio Company Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Diagnostic Imaging - A Prelude
    • Global Diagnostic Imaging Market Set for a Strong Growth
    • Developed Regions: The Dominant Markets for Diagnostic Imaging
    • Developing Regions Exhibit the Fastest Growth
    • Increase in Number of Hospitals & Clinics Infuses Momentum in Developing Regions
    • Key Players
    • Diagnostic Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Segment Analysis
    • MRI Dominates the Global Diagnostic Imaging Market
    • Computed Tomography System (CT Scanner)
    • Ultrasound
    • X-Ray
    • Nuclear Medicine
    • SPECT Dominates the Nuclear Medicine Market
  • PET
  • 2. FOCUS ON SELECT PLAYERS
    • Agfa-Gevaert N.V. (Belgium
    • Canon Medical Systems Corporation (Japan)
    • Carestream Health, Inc. (USA)
    • Esaote S.p.A. (Italy)
    • Fujifilm Corporation (Japan)
    • GE Healthcare (UK)
    • Koninklijke Philips N.V. (Netherlands)
    • Konica Minolta Inc. (Japan)
    • Hitachi Ltd. (Japan)
    • Hologic, Inc. (USA)
    • HOYA Group Pentax (Japan)
    • Samsung Medison Co., Ltd. (Korea)
    • Shimadzu Corporation (Japan)
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
    • Siemens Healthineers (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Rapidly Aging Population Spurs Demand for Diagnostic Imaging: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Rising Prevalence of Chronic Diseases Amplifies the Volume of Diagnostic Imaging Procedures: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rising Healthcare Expenditure Impels Global Market
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Technological Innovations Drive the Global Diagnostic Imaging Market
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
    • PET-CT: The Most Successful Fusion Imaging Technique
  • SPECT-CT
    • PET/MRI Continues to Makes Inroads
    • Ultrasound and MRI Imaging: An Efficient Combination
    • Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives Market Growth
    • CT Imaging Gains Popularity
    • CCTA Gaining Traction in Coronary Arteries Imaging
    • Use of Blockchain in Diagnostic Imaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for X-ray Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Diagnostic Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION